Product category:
Laboratory and scientific professional organisations
News Release from: Copper Development Association | Subject: Antimicrobial copper
Edited by the Laboratorytalk Editorial
Team on 27 March 2008
Copper in forefront of fight against C
Difficile
Researchers at the University of Southampton have established that copper surfaces can inactivate the virulent hospital superbug Clostridium difficile
The team, led by Professor Bill Keevil, showed that C difficile microbes placed on copper alloy surfaces died within one or two days On a stainless steel surface, the bacteria were still alive after a week
This article was originally published on Laboratorytalk on 31 Mar 2006 at 8.00am (UK)
Related stories
Copper could help prevent spread of flu infections
Recent research at the University of Southampton shows that the Influenza A virus is virtually eradicated within six hours on copper surfaces.
Copper could be the new weapon against superbugs
A Birmingham UK hospital will launch an 18-month clinical trial in April 2007 to establish whether the installation of copper surfaces will kill MRSA and other hospital-acquired infections
C difficile forms spores which are resistant to a range of disinfectants, including alcohol gel, which is recommended for routine use in hospitals.
These spores can live in the environment for a long time and are rapidly becoming a major cause of hospital acquired infections.
Latest figures from the Health Protection Agency show an alarming 72% increase in deaths from C difficile.
Further reading
Copper touch surfaces in healthcare facilities
Research demonstrates rapid antimicrobial activity of copper against MRSA with 99.9% inactivation in 90 minutes
New test could prevent more cervical cancer
A new test could be a more effective early warning system for preventing cervical cancer than the traditional smear according to Cancer Research UK scientists
The numbers have risen from 3,757 in 2005 to 6,480 in 2006.
The Southampton research team has already shown how effective copper can be in combating the MRSA hospital bug.
Exceptionally high levels of MRSA microbes were eliminated within 90 minutes of contact with a copper surface.
In the same tests, the bacteria remain alive on stainless steel surfaces for up to three days.
Lead researcher Professor Keevil says the new findings are particularly significant: "We've already shown that copper surfaces can inactivate MRSA microbes.
"The fact that we've now established that copper also inactivates C difficile spores, which are resistant to standard cleaning regimes, doubles our conviction that copper can play a significant role in helping hospitals to fight against infections".
The Southampton research provided the foundation for a year-long programme of testing, under the United States Environmental Protection Agency approved protocols, on 3000 samples of five different copper alloys in independent laboratories in the USA.
This has very recently led the US Environmental Protection Agency to officially register copper as an antimicrobial agent.
Copper is the first and only solid material to ever be registered by the EPA as antimicrobial.
Now, for the first time, products made from copper alloy can be marketed in the US making public health claims.
In the light of the research, Selly Oak Hospital in Birmingham, UK, has already begun a trial to demonstrate copper's antimicrobial properties in a clinical setting.
Frequently touched surfaces, such as door handles, grab rails, bathroom taps and light switches, have all been replaced with copper alloys in one ward.
Professor Tom Elliott, University Hospital Birmingham deputy medical director and leader of the Selly Oak copper clinical trial, believes copper could play a key role in the future to help contain hospital-acquired infections.
"Laboratory research has shown that MRSA and Clostridium difficile microbes die much more quickly when they come into contact with copper-based surfaces than on the usual surfaces you find in a hospital.
"It is an exciting development and, if the trial proves successful in a clinical setting, could provide the NHS Foundation Trust (UK) with yet another means of tackling the spread of health care-associated infections.".
• Copper Development Association: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
